- Report
- April 2022
- 58 Pages
Global
From €3323EUR$3,495USD£2,794GBP
- Report
- March 2022
- 41 Pages
Global
From €3323EUR$3,495USD£2,794GBP
- Drug Pipelines
- February 2022
- 150 Pages
Global
From €14257EUR$14,995USD£11,989GBP
- Drug Pipelines
- January 2022
- 84 Pages
Global
From €9503EUR$9,995USD£7,991GBP
- Report
- January 2024
- 244 Pages
Global
€4749EUR$4,995USD£3,994GBP
- Report
- February 2022
- 50 Pages
Global
From €3328EUR$3,500USD£2,798GBP
- Report
- February 2022
- 60 Pages
Global
From €1902EUR$2,000USD£1,599GBP
- Drug Pipelines
- March 2021
Global
From €1902EUR$2,000USD£1,599GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£951GBP

The Clinical Development market is a key component of the Drug Discovery process. It involves the testing of new drugs and treatments on human subjects in order to assess their safety and efficacy. Clinical Development typically involves a series of phases, beginning with pre-clinical trials and progressing through to Phase I, II, and III clinical trials. The results of these trials are used to determine whether a drug should be approved for use by regulatory authorities.
The Clinical Development market is highly competitive, with a range of companies offering services such as clinical trial design, data management, and regulatory consulting. These companies are often specialized in specific therapeutic areas, such as oncology, neurology, and cardiology. Examples of companies in the Clinical Development market include Parexel, ICON, and Syneos Health. Show Less Read more